{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:30:14Z","timestamp":1791311414284,"version":"4.3.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":1805,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC 97\u20132320-B-007\u2013001-MY3"],"award-info":[{"award-number":["NSC 97\u20132320-B-007\u2013001-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSC 98\u20132320-B-007\u2013004-MY3"],"award-info":[{"award-number":["NSC 98\u20132320-B-007\u2013004-MY3"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003711","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST 103\u20132320-B-007\u2013005"],"award-info":[{"award-number":["MOST 103\u20132320-B-007\u2013005"]}],"id":[{"id":"10.13039\/501100003711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["RO1 CA138188"],"award-info":[{"award-number":["RO1 CA138188"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Murst Cluster 03"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1074\/jbc.m115.676130","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T08:39:48Z","timestamp":1442565588000},"page":"26562-26575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy"],"prefix":"10.1016","volume":"290","author":[{"given":"Chien-Chung","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hsuan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hsin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bau-Lin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Errico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Luongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soldano","family":"Ferrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M115.676130_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M115.676130_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M115.676130_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1074\/jbc.M115.676130_bib4","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.M115.676130_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"10.1074\/jbc.M115.676130_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.0105-2896.2005.00316.x","article-title":"Mechanisms of MHC class I-restricted antigen processing and cross-presentation","volume":"207","author":"Cresswell","year":"2005","journal-title":"Immunol. Rev"},{"key":"10.1074\/jbc.M115.676130_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0065-230X(05)93006-6","article-title":"Classical and non-classical HLA class I antigen and NK cell activating ligand changes in malignant cells: current challenges and future directions","volume":"93","author":"Chang","year":"2005","journal-title":"Adv. Cancer Res"},{"key":"10.1074\/jbc.M115.676130_bib8","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1038\/onc.2008.273","article-title":"HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance","volume":"27","author":"Campoli","year":"2008","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M115.676130_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng0696-210","article-title":"A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer","volume":"13","author":"Chen","year":"1996","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M115.676130_bib10","first-page":"8647","article-title":"Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway","volume":"61","author":"Seliger","year":"2001","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.676130_bib11","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1158\/0008-5472.CAN-05-0044","article-title":"Immunoselective pressure and human leukocyte antigen class I antigen machinery defects in microsatellite unstable colorectal cancers","volume":"65","author":"Kloor","year":"2005","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M115.676130_bib12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2567.2007.02746.x","article-title":"Differential contribution of TAP and tapasin to HLA class I antigen expression","volume":"124","author":"Belicha-Villanueva","year":"2008","journal-title":"Immunology"},{"key":"10.1074\/jbc.M115.676130_bib13","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4049\/jimmunol.174.3.1462","article-title":"Immune selection of hot-spot \u03b22-microglobulin gene mutations, HLA-A2 allospecificity loss and antigen processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy","volume":"174","author":"Chang","year":"2005","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib14","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.4049\/jimmunol.174.11.6863","article-title":"Sequential immune escape and shifting of T cell responses in a long-term survivor of melanoma","volume":"174","author":"Yamshchikov","year":"2005","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00262-006-0183-1","article-title":"Immune selective pressure and HLA class I antigen defects in malignant lesions","volume":"56","author":"Chang","year":"2007","journal-title":"Cancer Immunol. Immunother"},{"key":"10.1074\/jbc.M115.676130_bib16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.semcancer.2003.09.003","article-title":"Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine","volume":"13","author":"Hsueh","year":"2003","journal-title":"Semin. Cancer Biol"},{"key":"10.1074\/jbc.M115.676130_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(78)90296-9","article-title":"Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens-new tools for genetic analysis","volume":"14","author":"Barnstable","year":"1978","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.676130_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"key":"10.1074\/jbc.M115.676130_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1034\/j.1399-0039.2003.00087.x","article-title":"Specificity and functional characteristics of anti-HLA-A mAbs LGIII-147.4.1 and LGIII-220.6.2","volume":"62","author":"Wang","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1074\/jbc.M115.676130_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1399-0039.1983.tb01176.x","article-title":"Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies","volume":"22","author":"Reba\u00ef","year":"1983","journal-title":"Tissue Antigens"},{"key":"10.1074\/jbc.M115.676130_bib21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.4049\/jimmunol.137.7.2299","article-title":"Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products","volume":"137","author":"Stam","year":"1986","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-5890(98)00026-1","article-title":"Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents","volume":"35","author":"Sernee","year":"1998","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib23","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4049\/jimmunol.171.4.1918","article-title":"\u03b22-Microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide","volume":"171","author":"Perosa","year":"2003","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib24","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.4049\/jimmunol.130.5.2471","article-title":"Striking paucity of HLA-A, -,B, -,C and \u03b22-microglobulin on human neuroblastoma cell lines","volume":"130","author":"Lampson","year":"1983","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1399-0039.2005.00462.x","article-title":"Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies","volume":"66","author":"Bandoh","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1074\/jbc.M115.676130_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jim.2005.02.006","article-title":"A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections","volume":"299","author":"Wang","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1074\/jbc.M115.676130_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1034\/j.1399-0039.2003.00114.x","article-title":"Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining","volume":"62","author":"Ogino","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1074\/jbc.M115.676130_bib28","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.143.11.3844","article-title":"Characterization of syngeneic antiidiotypic monoclonal antibodies to murine anti-human high molecular weight melanoma-associated antigen monoclonal antibodies","volume":"143","author":"Kusama","year":"1989","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0198-8859(88)90061-4","article-title":"Syngeneic antiidiotypic monoclonal antibodies to the murine anti-HLA-DR, DP monoclonal antibody CR11\u2013462","volume":"23","author":"Perosa","year":"1988","journal-title":"Hum. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1034\/j.1399-0039.2000.550507.x","article-title":"Criteria to define HLA haplotype loss in human solid tumors","volume":"55","author":"Ramal","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1074\/jbc.M115.676130_bib31","first-page":"841","article-title":"Identification of a gp100 epitope recognized by HLA-A3 restricted melanoma infiltrating lymphocytes","volume":"10","author":"Moreau-Aubry","year":"1997","journal-title":"Int. J. Oncol"},{"key":"10.1074\/jbc.M115.676130_bib32","doi-asserted-by":"crossref","first-page":"18763","DOI":"10.1074\/jbc.M511525200","article-title":"Defective HLA class I-associated antigen presentation caused by a novel \u03b22-microglobulin loss-of-function in melanoma cells","volume":"281","author":"Chang","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M115.676130_bib33","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1128\/MCB.25.11.4727-4741.2005","article-title":"5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal","volume":"25","author":"Ghoshal","year":"2005","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M115.676130_bib34","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.277.5330.1306","article-title":"A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes","volume":"277","author":"Ortmann","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.M115.676130_bib35","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1182\/blood-2001-12-0252","article-title":"A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination","volume":"100","author":"Yabe","year":"2002","journal-title":"Blood"},{"key":"10.1074\/jbc.M115.676130_bib36","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jnci\/djt184","article-title":"MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells","volume":"105","author":"Leone","year":"2013","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/jbc.M115.676130_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<91::AID-IJC17>3.0.CO;2-4","article-title":"Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors","volume":"83","author":"Jim\u00e9nez","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M115.676130_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.1452","article-title":"Reexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cell following 5-aza-2\u2032-deoxycytidine treatment","volume":"94","author":"Serrano","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1074\/jbc.M115.676130_bib39","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/carcin\/22.10.1615","article-title":"DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas","volume":"22","author":"Nie","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1074\/jbc.M115.676130_bib40","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-2407-7-34","article-title":"Distinct mechanisms of loss of IFN-\u03b3-mediated HLA class I inducibility in two melanoma cell lines","volume":"7","author":"Rodr\u00edguez","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1074\/jbc.M115.676130_bib41","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.7314\/APJCP.2014.15.23.10299","article-title":"Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma","volume":"15","author":"Sheyhidin","year":"2014","journal-title":"Asian Pac. J. Cancer Prev"},{"key":"10.1074\/jbc.M115.676130_bib42","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/cam4.451","article-title":"Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma","volume":"4","author":"Dai","year":"2015","journal-title":"Cancer Med"},{"key":"10.1074\/jbc.M115.676130_bib43","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002510050425","article-title":"Regulation of MHC class I and II gene transcription: differences and similarities","volume":"48","author":"van den Elsen","year":"1998","journal-title":"Immunogenetics"},{"key":"10.1074\/jbc.M115.676130_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0092-8674(00)81656-6","article-title":"DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development","volume":"99","author":"Okano","year":"1999","journal-title":"Cell"},{"key":"10.1074\/jbc.M115.676130_bib45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1074-7613(00)80474-4","article-title":"Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220","volume":"8","author":"Lehner","year":"1998","journal-title":"Immunity"},{"key":"10.1074\/jbc.M115.676130_bib46","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.4049\/jimmunol.168.4.1950","article-title":"Recruitment of MHC class I molecules by tapasin into the transporter associated with antigen processing-associated complex is essential for optimal peptide loading","volume":"168","author":"Tan","year":"2002","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib47","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.4049\/jimmunol.1302637","article-title":"Three tapasin docking sites in TAP cooperate to facilitate transporter stabilization and heterodimerization","volume":"192","author":"Leonhardt","year":"2014","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0161-5890(02)00103-7","article-title":"Tapasin-the keystone of the loading complex optimizing peptide binding by MHC class I molecules in the endoplasmic reticulum","volume":"39","author":"Momburg","year":"2002","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1074-7613(02)00304-7","article-title":"Optimization of the MHC class I peptide cargo is dependent on tapasin","volume":"16","author":"Williams","year":"2002","journal-title":"Immunity"},{"key":"10.1074\/jbc.M115.676130_bib50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00403-003-0393-8","article-title":"Down-regulation of tapasin expression in progressive human malignant melanoma","volume":"295","author":"Dissemond","year":"2003","journal-title":"Arch Dermatol. Res"},{"key":"10.1074\/jbc.M115.676130_bib51","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/eji.1830250206","article-title":"Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection","volume":"25","author":"Lehmann","year":"1995","journal-title":"Eur. J. Immunol"},{"key":"10.1074\/jbc.M115.676130_bib52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/bjh.12256","article-title":"Korean Society of Haematology AML\/MDS working party: comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes","volume":"161","author":"Lee","year":"2013","journal-title":"Br. J. Haematol"},{"key":"10.1074\/jbc.M115.676130_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-12-380866-0.60012-5","article-title":"DNA demethylating agents and epigenetic therapy of cancer","volume":"70","author":"Mani","year":"2010","journal-title":"Adv. Genet"},{"key":"10.1074\/jbc.M115.676130_bib54","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1158\/1078-0432.CCR-06-0883","article-title":"Phase I trial of sequential low-dose 5-aza-2\u2032-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma","volume":"12","author":"Gollob","year":"2006","journal-title":"Clin. Cancer Res"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820495316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820495316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M115.676130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T07:38:42Z","timestamp":1691998722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820495316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":54,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0021925820495316"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m115.676130","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M115.676130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}